BackgroundCheck.run
Search For

Elizabeth W Kwong, 671784 Midlothian Dr, Altadena, CA 91001

Elizabeth Kwong Phones & Addresses

1784 Midlothian Dr, Altadena, CA 91001    626-7948878   

Pasadena, CA   

116 Sheridan Ter, Ridgewood, NJ 07450    626-7948878   

Bellevue, WA   

Los Angeles, CA   

Santa Monica, CA   

Montvale, NJ   

1784 Midlothian Dr, Altadena, CA 91001    626-6449628   

Work

Position: Private Household Service Occupations

Education

School / High School: University of California At San Diego 2001

Languages

English

Mentions for Elizabeth W Kwong

Career records & work history

Medicine Doctors

Elizabeth Kwong Photo 1

Elizabeth M Kwong, Glendale CA

Specialties:
Anatomic & Clinical Pathology
Address:
904 Calle Canta, Glendale, CA 91208
Languages:
English
Education:
Medical School
University of California At San Diego
Graduated: 2001

Elizabeth Kwong resumes & CV records

Resumes

Elizabeth Kwong Photo 20

Elizabeth Kwong

Elizabeth Kwong Photo 21

Elizabeth Kwong

Location:
United States

Publications & IP owners

Us Patents

Transdermally Administered Aliskiren

US Patent:
2011023, Sep 29, 2011
Filed:
Nov 23, 2009
Appl. No.:
13/131058
Inventors:
Sylvie Toulmond - Beaconsfield, CA
Elizabeth Kwong - Cranford NJ, US
Dwight MacDonald - L'lle Bizard, CA
International Classification:
A61K 31/165
A61K 31/724
A61P 9/12
A61P 9/10
A61P 9/00
A61N 1/30
A61M 37/00
A61M 5/00
A61M 5/30
US Classification:
514 58, 514620, 604 20, 604 22, 604272, 604 68
Abstract:
Dosage form of aliskiren, comprising a device for transdermal administration of aliskiren and aliskiren (including salts, prodrugs and metabolites thereof), optionally together with pharmaceutically acceptable carrier(s) to a human being or an animal in order to achieve a desired therapeutic effect. Use of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s), for the manufacture of a composition to be administered transdermally for achieving a desired therapeutic effect. Method for achieving a desired therapeutic effect by transdermal administration of a compound comprising aliskiren, optionally encompassing salts, prodrugs and metabolites thereof, and optionally together with pharmaceutically acceptable carrier(s).

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.